Hyoscyamine Contraindications in Myasthenia Gravis

Mechanism and Risks

• Hyoscyamine is an anticholinergic medication with muscarinic antagonist properties that can interfere with neuromuscular transmission in myasthenia gravis patients 1
• The American Society of Clinical Oncology guidelines specifically list anticholinergic medications among those that should be avoided in myasthenia gravis 1, 2
• Medications with anticholinergic properties can counteract the beneficial effects of acetylcholinesterase inhibitors (like pyridostigmine) that are commonly used to treat myasthenia gravis 3

Medication Considerations for Myasthenia Gravis

• The American Society of Clinical Oncology guidelines explicitly state to "avoid medications that can worsen myasthenia," including anticholinergics 1

Alternative Approaches

• For patients with myasthenia gravis requiring treatment for conditions where anticholinergics might typically be used, consultation with neurology is recommended to determine safer alternatives 4

Monitoring and Precautions

• Assessment of respiratory function (vital capacity and negative inspiratory force) should be performed before and after administration of any medication that may potentially exacerbate myasthenia gravis 1, 4